Nuvectis Pharma (NVCT) Balance Sheet: Assets & Liabilities

Nuvectis Pharma (NVCT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Nuvectis Pharma reported total assets of $31.71M and total liabilities of $13.30M. Shareholders' equity was $18.41M, up 89.6% from $9.71M a year earlier. Total debt stood at $0.00 against $31.63M in cash and short-term investments, a net cash position of $31.63M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Nuvectis Pharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Nuvectis Pharma, Inc. (NVCT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	31.63	18.53	19.13	19.99	5.74	0.00
Cash & Short-Term Investments	31.63	18.53	19.13	19.99	5.74	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.08	0.07	0.06	0.41	0.92	0.00
Total Current Assets	31.71	18.61	19.19	20.41	5.83	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.82	0.00
Total Non-Current Assets	0.00	0.00	0.00	0.00	0.82	0.00
Total Assets	31.71	18.61	19.19	20.41	6.66	0.00
Current Liabilities
Accounts Payable	6.27	2.50	2.77	2.91	1.06	0.01
Accrued Liabilities	7.02	6.40	4.21	2.83	0.54	-
Other Current Liabilities	7.02	6.40	4.21	0.45	0.82	0.00
Total Current Liabilities	13.30	8.89	6.98	6.19	2.42	0.01
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	15.25	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	15.25	0.00
Total Liabilities	13.30	8.89	6.98	6.19	2.42	0.01
Stockholders' Equity
Retained Earnings	-99.69	-73.25	-54.25	-31.99	-12.90	-0.01
Additional Paid-in Capital	118.10	82.96	66.45	46.20	1.89	0.00
Shares Outstanding	25.68	19.50	17.42	14.64	-	-
Total Stockholders' Equity	18.41	9.71	12.20	14.22	4.24	-0.01
Total Liabilities & Equity	31.71	18.61	19.19	20.41	6.66	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Nuvectis Pharma Balance Sheet

How much debt does Nuvectis Pharma have?

Nuvectis Pharma had total debt of $0.00 as of Dec 31, 2025, against $31.63M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Nuvectis Pharma's total assets?

Nuvectis Pharma reported total assets of $31.71M as of Dec 31, 2025, up 70.4% from $18.61M a year earlier. Total liabilities were $13.30M.

What is Nuvectis Pharma's shareholders' equity?

Nuvectis Pharma's shareholders' equity was $18.41M as of Dec 31, 2025, or about $0.72 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition